Monoclonal Antibody Defined Antigens in Breast Cancer

Mesa-Tejada, Ricardo

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 7R01CA032984-05
• Application #: 3170891
• Study Section: Pathology B Study Section (PTHB)
• Project Start: 1987-10-01
• Project End: 1990-03-31
• Budget Start: 1987-10-01
• Budget End: 1988-03-31
• Support Year: 5
• Fiscal Year: 1987

Institution

• Name: Metpath, Inc.
• City: Teterboro
• State: NJ
• Country: United States
• Zip Code: 07608

Publications

Hayes, D F; Mesa-Tejada, R; Papsidero, L D et al. (1991) Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study. J Clin Oncol 9:1113-23

Yemul, S; Leon, J A; Seldin, D W et al. (1991) Tumor localization in nude mice bearing human breast carcinoma xenografts using 111In-DTPA conjugates of monoclonal antibodies. Int J Rad Appl Instrum B 18:295-304

Leon, J A; Mesa-Tejada, R; Gutierrez, M C et al. (1989) Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. Anticancer Res 9:1639-47

Estabrook, A; Mesa-Tejada, R (1989) Monoclonal antibodies: their importance to surgeons. J Invest Surg 2:211-22

Mesa-Tejada, R; Palakodety, R B; Leon, J A et al. (1988) Immunocytochemical distribution of a breast carcinoma associated glycoprotein identified by monoclonal antibodies. Am J Pathol 130:305-14